Posttraumatic focal dystonia of the shoulder.
Focal posttraumatic shoulder dystonia is a rare and not easily identifiable entity. Its true pathophysiologic nature, predisposing factors, and disease course remain debatable.This article describes a rare case of a 40-year-old man with late symptoms of focal shoulder dystonia after peripheral trauma of his left shoulder girdle. The shoulder was indirectly injured from the impact of a fall off his motorbike 3 years earlier. He was referred to the authors' institution because remarkable reduction of arm abduction, muscle spasms, and circumscribed hypertrophy of the trapezius muscle were noted while his head and neck were in neutral position and had a full range of motion. The left shoulder had a fixed elevated posture compared with the contralateral shoulder. A continuous burning pain was localized over the area of the hypertrophied trapezius muscle, radiating to the ipsilateral side of the head and neck. Dystonic movements of the trapezius, rhomboid, and supraspinatus muscles were observed. The abduction of the shoulder was significantly decreased, and any repetitive effort for arm abduction induced an exaggeration of his movement disorder, leading to a more pronounced shoulder elevation.Plain radiographs and magnetic resonance imaging of the left shoulder revealed a suprascapular tendinitis with no other abnormalities. Repeated needle electromyography of the left trapezius muscle and neurography of the accessory nerve on both sides were normal. Injections of botulinum toxin A were effective in the resolution of muscle hypertrophy and abnormal posture.
First Department of Orthopaedics, ATTIKON University General Hospital, Chaidari, Greece. b_sakellariou@yahoo.com
Georgios I
GI
Vasileiadis
Vasileios I
VI
Sakellariou
Panayiotis J
PJ
Papagelopoulos
Aristeides B
AB
Zoubos
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D020821:Dystonic Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D008297:Male; D009465:Neuromuscular Agents / Q000627:therapeutic use; D000070599:Shoulder Injuries; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A